Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2578536rdf:typepubmed:Citationlld:pubmed
pubmed-article:2578536lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:2578536lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:2578536lifeskim:mentionsumls-concept:C0456981lld:lifeskim
pubmed-article:2578536lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2578536lifeskim:mentionsumls-concept:C1553423lld:lifeskim
pubmed-article:2578536lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2578536lifeskim:mentionsumls-concept:C0163054lld:lifeskim
pubmed-article:2578536pubmed:issue2lld:pubmed
pubmed-article:2578536pubmed:dateCreated1985-2-26lld:pubmed
pubmed-article:2578536pubmed:abstractTextThe present study examined the effect of pulse treatment with the in vitro active synthetic derivative of cyclophosphamide (CY), 4-hydroperoxycyclophosphamide (4-HPCY), and exposure to X-irradiation on the in vitro Concanavalin A (ConA), lipopolysaccharide (LPS), and antigen-specific blastogenic responses of in vivo-primed lymph node cells. Primed lymph node cells from CY-pretreated, aggregated (A) human IgG-complete Freund's adjuvant (AHGG-CFA)-immunized mice were untreated, exposed to various doses of irradiation, or pulse treated with different concentrations of 4-HPCY before being cultured in medium alone or in medium containing HGG, ConA, or LPS. The results show that HGG-responding and LPS-responding cells exhibited similar dose-inactivation profiles following exposure to irradiation or pulse treatment with 4-HPCY. More than 75% of reactivity was eliminated by exposure to 100 rads or pulse treatment with 20 microM 4-HPCY. In contrast to preculture pulse treatment with 4-HPCY, however, when primed lymph node cells were cultured in medium containing 4-HPCY (culture treatment) LPS-responding cells were shown to be more sensitive to inactivation than HGG-responding cells. The data further show that the effect of low-dose irradiation and of culture treatment with 4-HPCY on the HGG-specific response of primed lymph node cells was additive, suggesting that these agents inactivate different cell subtypes that contribute to the HGG-specific response in vitro.lld:pubmed
pubmed-article:2578536pubmed:languageenglld:pubmed
pubmed-article:2578536pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:citationSubsetIMlld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2578536pubmed:statusMEDLINElld:pubmed
pubmed-article:2578536pubmed:monthFeblld:pubmed
pubmed-article:2578536pubmed:issn0741-5400lld:pubmed
pubmed-article:2578536pubmed:authorpubmed-author:ClarkCClld:pubmed
pubmed-article:2578536pubmed:authorpubmed-author:BorchR FRFlld:pubmed
pubmed-article:2578536pubmed:authorpubmed-author:LaSotaIIlld:pubmed
pubmed-article:2578536pubmed:issnTypePrintlld:pubmed
pubmed-article:2578536pubmed:volume37lld:pubmed
pubmed-article:2578536pubmed:ownerNLMlld:pubmed
pubmed-article:2578536pubmed:authorsCompleteYlld:pubmed
pubmed-article:2578536pubmed:pagination175-91lld:pubmed
pubmed-article:2578536pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:meshHeadingpubmed-meshheading:2578536-...lld:pubmed
pubmed-article:2578536pubmed:year1985lld:pubmed
pubmed-article:2578536pubmed:articleTitleEvidence that X-irradiation and 4-hydroperoxycyclophosphamide affects different lymphocytes that respond to specific antigen in vitro.lld:pubmed
pubmed-article:2578536pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2578536pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2578536lld:pubmed